<p>一種臨牀上可靠的線粒體評估，將先進的細胞測試轉化為可操作的見解，以優化能量、代謝和個性化表現。</p>
<p>, /PRNewswire/ -- 10X Health System 是一家專注於數據驅動的人類優化的精準健康公司，今天宣佈通過與 Verséa Discovery, Inc.的戰略合作，推出 10X MitoScreen™，一種先進的線粒體健康評估，利用他們的 mescreenTM 技術。10X MitoScreen™旨在提供對線粒體功能和效率的更深入洞察，以及其在代謝韌性、表現和長期健康優化中的作用，預計將在 2026 年第一季度向從業者和消費者提供。現在，特定個體可以獨家提前體驗這一突破性的評估。</p>
<p>繼續閲讀</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>10X Health System 與 Verséa Discovery 合作推出 10X MitoScreen™，這是一種下一代線粒體評估，提供對能量、代謝和表現的更深入洞察。該技術基於在先進研究環境中驗證的技術，這一突破將臨牀上可靠的線粒體智能引入現實世界的健康優化——幫助個人和從業者向上遊轉向主動、個性化的護理。</p>
<p>線粒體驅動細胞能量和代謝健康，但直到現在，線粒體的測量很少同時具備科學嚴謹性和現實臨牀相關性。通過與 Verséa Discovery 的合作，10X Health 正在擴展其精準測試生態系統，推出 10X MitoScreen™，幫助將健康優化從症狀管理轉向根本原因的理解。</p>
<p>10X MitoScreen™背後的技術最初是在 NASA 雙胞胎研究中開發和驗證的，這是一項標誌性的研究，考察了人類在極端太空條件下的表現、韌性和恢復。這一科學基礎使得能夠評估線粒體的功能、結構和效率，並提供一種在消費者可接觸的測試中罕見的生物可視化水平。</p>
<p>10X MitoScreen™使用簡單的指尖血樣分析實際線粒體功能和代謝效率的關鍵方面。該評估評估線粒體健康的多個維度，包括能量生產、代謝平衡、氧化壓力和線粒體網絡動態，生成一個綜合的線粒體檔案和評分。</p>
<p>結果提供了線粒體表現和適應能力的結構化概述，可用於建立個人基線、跟蹤隨時間的變化，並在未來健康優化策略中提供信息，隨着額外的解釋和基於協議的服務的可用性。</p>
<p>“與 Verséa Discovery 的合作使我們能夠擴展對先進生物見解的獲取，這曾經僅限於研究環境，”<strong>10X Health System 的聯合創始人兼首席執行官 Brandon Dawson</strong> 表示。“通過 10X MitoScreen™，個人和從業者可以更清晰地瞭解細胞層面發生的事情——解鎖更精確和主動的健康優化方法。”</p>
<p>“基於多年的研究，我們的目標是將可測量、可追蹤的細胞和線粒體健康帶給世界——推動慢性疾病、長壽科學和精英運動表現的進步，”<strong>Verséa Discovery 的聯合創始人兼首席執行官 Sean Fetcho</strong> 表示。“我們與 10X Health 的合作將我們的技術整合到更廣泛的精準健康生態系統中，確保結果不僅僅是提供信息——而是直接塑造個性化的優化策略。”</p>
<p>10X MitoScreen™將在 2026 年第一季度作為 10X Health System 不斷擴展的精準測試組合的一部分提供，支持尋求對人類表現和長壽有更深入洞察的消費者、臨牀醫生和企業合作伙伴。</p>
<p>通過 Verséa Discovery 的 mescreenTM 技術，現在可以提前訪問該測試，訪問 https://mitoscreen.com</p>
<p><strong>關於 10X HEALTH SYSTEM</strong> 10X Health System 是一家精準健康公司，重新定義人們如何理解、優化和掌控自己的健康。基於沒有兩個個體是相同的信念，10X Health 用數據驅動的見解取代一刀切的方法，利用先進的基因測試、血液分析和新興診斷來揭示表現、能量和長期健康結果背後的根本原因。</p>
<p>通過將複雜的生物數據轉化為清晰、可操作的營養、補充、生活方式和臨牀治療建議，10X Health 使個人和組織能夠從反應性護理轉向主動、個性化的健康優化。該公司服務於消費者、臨牀醫生和企業合作伙伴，正在建立精準健康的新標準——一個數據獲取創造清晰度、自信和對人類表現和長壽產生可衡量影響的標準。</p>
<p><strong>關於 VERSÉA DISCOVERY</strong> Verséa Discovery, Inc.是一家總部位於美國的精準醫學公司，開創了細胞和線粒體健康技術。其專有的_mescreen™_技術最初在先進的研究環境中得到驗證，現在正在為消費者、診所和研究機構提供下一代精準健康見解。</p>
<p>照片 - https://mma.prnewswire.com/media/2869561/Partnership.jpg</p>
<p>標誌 - https://mma.prnewswire.com/media/2869342/10XHealth_Logo.jpg</p>
<p>來源 10X Health System; Verséa Discovery, Inc</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI2Jk5ld3NJdGVtSWQ9TE43MDcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjYxMTQxUFJfTkVXU19VU1BSX19fX19MTjcwNzAz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI2Jk5ld3NJdGVtSWQ9TE43MDcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjYxMTQxUFJfTkVXU19VU1BSX19fX19MTjcwNzAz"/></p>

<p>10X Health System 與 Verséa Discovery 合作推出了 10X MitoScreen™，這是一種下一代線粒體評估測試。該臨牀穩健的評估旨在提供對線粒體功能、能量生產和代謝健康的洞察。預計將在 2026 年第一季度上市，允許醫生和消費者通過簡單的血樣跟蹤線粒體健康。目前，部分個人可以提前獲得該測試。該測試基於在 NASA 雙胞胎研究中驗證的技術，增強了個性化健康優化策略</p>

<p>A clinically robust mitochondrial assessment that transforms advanced cellular testing into actionable insights for optimized energy, metabolism, and personalized performance.</p>
<div class="lb-trans"><p>一種臨牀上可靠的線粒體評估，將先進的細胞測試轉化為可操作的見解，以優化能量、代謝和個性化表現。</p>
</div><p>, /PRNewswire/ -- 10X Health System, a precision wellness company focused on data-driven human optimization, today announced the addition of 10X MitoScreen™, an advanced mitochondrial health assessment, through a strategic partnership with Verséa Discovery, Inc. leveraging their mescreenTM technology. Designed to provide deeper insight into mitochondrial function &amp; efficiency as well as its role in metabolic resilience, performance, and long-term health optimization, 10X MitoScreen™ will be available in the first quarter of 2026 for both practitioners and consumers. Exclusive early access is now available for select individuals seeking to experience this groundbreaking assessment.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 10X Health System 是一家專注於數據驅動的人類優化的精準健康公司，今天宣佈通過與 Verséa Discovery, Inc.的戰略合作，推出 10X MitoScreen™，一種先進的線粒體健康評估，利用他們的 mescreenTM 技術。10X MitoScreen™旨在提供對線粒體功能和效率的更深入洞察，以及其在代謝韌性、表現和長期健康優化中的作用，預計將在 2026 年第一季度向從業者和消費者提供。現在，特定個體可以獨家提前體驗這一突破性的評估。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>繼續閲讀</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>10X Health System and Verséa Discovery have partnered to launch 10X MitoScreen™, a next-generation mitochondrial assessment delivering deeper insight into energy, metabolism, and performance. Built on technology validated in advanced research environments, this breakthrough brings clinically robust mitochondrial intelligence into real-world health optimization—helping individuals and practitioners move upstream toward proactive, personalized care.</p>
<div class="lb-trans"><p>10X Health System 與 Verséa Discovery 合作推出 10X MitoScreen™，這是一種下一代線粒體評估，提供對能量、代謝和表現的更深入洞察。該技術基於在先進研究環境中驗證的技術，這一突破將臨牀上可靠的線粒體智能引入現實世界的健康優化——幫助個人和從業者向上遊轉向主動、個性化的護理。</p>
</div><p>Mitochondria drive cellular energy and metabolic health, yet until now have rarely been measured with both scientific rigor and real-world clinical relevance. Through its partnership with Verséa Discovery, 10X Health is expanding its precision testing ecosystem with 10X MitoScreen™, helping move health optimization upstream from symptom management to root-cause understanding.</p>
<div class="lb-trans"><p>線粒體驅動細胞能量和代謝健康，但直到現在，線粒體的測量很少同時具備科學嚴謹性和現實臨牀相關性。通過與 Verséa Discovery 的合作，10X Health 正在擴展其精準測試生態系統，推出 10X MitoScreen™，幫助將健康優化從症狀管理轉向根本原因的理解。</p>
</div><p>The technology underlying 10X MitoScreen™ was originally developed and validated during the NASA Twins Study, a landmark investigation examining human performance, resilience, and recovery under extreme conditions in space. This scientific foundation enables assessment of mitochondrial function, structure &amp; efficiencies, and provides a level of biologic visibility rarely available in consumer-accessible testing.</p>
<div class="lb-trans"><p>10X MitoScreen™背後的技術最初是在 NASA 雙胞胎研究中開發和驗證的，這是一項標誌性的研究，考察了人類在極端太空條件下的表現、韌性和恢復。這一科學基礎使得能夠評估線粒體的功能、結構和效率，並提供一種在消費者可接觸的測試中罕見的生物可視化水平。</p>
</div><p>10X MitoScreen™ analyzes key aspects of actual mitochondrial function and metabolic efficiency using a simple finger prick blood sample. The assessment evaluates multiple dimensions of mitochondrial health, including energy production, metabolic balance, oxidative stress, and mitochondrial network dynamics, generating an integrated mitochondrial profile and score.</p>
<div class="lb-trans"><p>10X MitoScreen™使用簡單的指尖血樣分析實際線粒體功能和代謝效率的關鍵方面。該評估評估線粒體健康的多個維度，包括能量生產、代謝平衡、氧化壓力和線粒體網絡動態，生成一個綜合的線粒體檔案和評分。</p>
</div><p>Results provide a structured overview of mitochondrial performance and adaptive capacity and may be used to establish a personal baseline, track changes over time, and inform future health optimization strategies as additional interpretive and protocol-based services become available.</p>
<div class="lb-trans"><p>結果提供了線粒體表現和適應能力的結構化概述，可用於建立個人基線、跟蹤隨時間的變化，並在未來健康優化策略中提供信息，隨着額外的解釋和基於協議的服務的可用性。</p>
</div><p>&#34;Partnering with Verséa Discovery allows us to expand access to advanced biological insights that was once limited to research environments,&#34; said <strong>Brandon Dawson, Co-Founder and CEO of 10X Health System</strong>. &#34;With 10X MitoScreen™, individuals and practitioners gain a clearer view of what's happening at the cellular level—unlocking more precise and proactive approaches to health optimization.&#34;</p>
<div class="lb-trans"><p>“與 Verséa Discovery 的合作使我們能夠擴展對先進生物見解的獲取，這曾經僅限於研究環境，”<strong>10X Health System 的聯合創始人兼首席執行官 Brandon Dawson</strong> 表示。“通過 10X MitoScreen™，個人和從業者可以更清晰地瞭解細胞層面發生的事情——解鎖更精確和主動的健康優化方法。”</p>
</div><p>&#34;Built on years of research, our purpose is to bring measurable, trackable cellular and mitochondrial health to the world—fueling progress in chronic disease, longevity science, and elite athletic performance,&#34; said <strong>Sean Fetcho, Co-Founder and CEO of Verséa Discovery</strong>. &#34;Our partnership with 10X Health integrates our technology into a broader precision health ecosystem, ensuring results don't merely inform—but directly shape personalized optimization strategies.&#34;</p>
<div class="lb-trans"><p>“基於多年的研究，我們的目標是將可測量、可追蹤的細胞和線粒體健康帶給世界——推動慢性疾病、長壽科學和精英運動表現的進步，”<strong>Verséa Discovery 的聯合創始人兼首席執行官 Sean Fetcho</strong> 表示。“我們與 10X Health 的合作將我們的技術整合到更廣泛的精準健康生態系統中，確保結果不僅僅是提供信息——而是直接塑造個性化的優化策略。”</p>
</div><p>10X MitoScreen™ will be available in the first quarter 2026 as part of 10X Health System's expanding precision testing portfolio, supporting consumers, clinicians, and enterprise partners seeking deeper insight into human performance and longevity.</p>
<div class="lb-trans"><p>10X MitoScreen™將在 2026 年第一季度作為 10X Health System 不斷擴展的精準測試組合的一部分提供，支持尋求對人類表現和長壽有更深入洞察的消費者、臨牀醫生和企業合作伙伴。</p>
</div><p>Early access to the test via Verséa Discovery's mescreenTM technology can be done now by going to https://mitoscreen.com</p>
<div class="lb-trans"><p>通過 Verséa Discovery 的 mescreenTM 技術，現在可以提前訪問該測試，訪問 https://mitoscreen.com</p>
</div><p><strong>ABOUT 10X HEALTH SYSTEM</strong> 10X Health System is a precision wellness company redefining how people understand, optimize, and take control of their health. Founded on the belief that no two individuals are the same, 10X Health replaces one-size-fits-all approaches with data-driven insight, using advanced genetic testing, blood analysis, and emerging diagnostics to uncover the root causes behind performance, energy, and long-term health outcomes.</p>
<div class="lb-trans"><p><strong>關於 10X HEALTH SYSTEM</strong> 10X Health System 是一家精準健康公司，重新定義人們如何理解、優化和掌控自己的健康。基於沒有兩個個體是相同的信念，10X Health 用數據驅動的見解取代一刀切的方法，利用先進的基因測試、血液分析和新興診斷來揭示表現、能量和長期健康結果背後的根本原因。</p>
</div><p>By translating complex biological data into clear, actionable recommendations across nutrition, supplementation, lifestyle, and clinical therapies, 10X Health empowers individuals and organizations to move from reactive care to proactive, personalized health optimization. Serving consumers, clinicians, and enterprise partners, the company is building a new standard for precision wellness - one where access to data creates clarity, confidence, and measurable impact on human performance and longevity.</p>
<div class="lb-trans"><p>通過將複雜的生物數據轉化為清晰、可操作的營養、補充、生活方式和臨牀治療建議，10X Health 使個人和組織能夠從反應性護理轉向主動、個性化的健康優化。該公司服務於消費者、臨牀醫生和企業合作伙伴，正在建立精準健康的新標準——一個數據獲取創造清晰度、自信和對人類表現和長壽產生可衡量影響的標準。</p>
</div><p><strong>ABOUT VERSÉA DISCOVERY</strong> Verséa Discovery, Inc. is a U.S.-based precision medicine company pioneering cellular and mitochondrial health technologies. Its proprietary <em>mescreen™</em> technology was first validated in advanced research settings and is now driving next-generation precision health insights to consumers, clinics and research institutions.</p>
<div class="lb-trans"><p><strong>關於 VERSÉA DISCOVERY</strong> Verséa Discovery, Inc.是一家總部位於美國的精準醫學公司，開創了細胞和線粒體健康技術。其專有的_mescreen™_技術最初在先進的研究環境中得到驗證，現在正在為消費者、診所和研究機構提供下一代精準健康見解。</p>
</div><p>Photo - https://mma.prnewswire.com/media/2869561/Partnership.jpg</p>
<div class="lb-trans"><p>照片 - https://mma.prnewswire.com/media/2869561/Partnership.jpg</p>
</div><p>Logo - https://mma.prnewswire.com/media/2869342/10XHealth_Logo.jpg</p>
<div class="lb-trans"><p>標誌 - https://mma.prnewswire.com/media/2869342/10XHealth_Logo.jpg</p>
</div><p>SOURCE 10X Health System; Verséa Discovery, Inc</p>
<div class="lb-trans"><p>來源 10X Health System; Verséa Discovery, Inc</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI2Jk5ld3NJdGVtSWQ9TE43MDcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjYxMTQxUFJfTkVXU19VU1BSX19fX19MTjcwNzAz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LN70703&amp;Transmission_Id=202601261141PR_NEWS_USPR_____LN70703&amp;DateId=20260126"/></p>

11:41 ET
			
			
				10X Health System and Verséa Discovery Launch 10X MitoScreen™, a Next-Generation Mitochondrial Assessment Test

prnewswire

華夏上證科創板生物醫藥ETF

SunLink衞生系統

CS精準醫

易方達滬深300醫藥ETF

國泰中證生物醫藥ETF

醫藥突破 ETF - ALPS

Sequoia Vaccines, Inc.

標普全球醫療股指數 ETF - iShares

基因改革 ETF - ARK

華夏醫藥ETF

納斯達克生物科技指數 ETF - iShares Nasdaq

2 倍做多納斯達克生物技術 ETF - ProShares

美國制藥 ETF - iShares

生物科技 ETF - VanEck Vectors

醫療業 ETF - SPDR

生物科技ETF基金

標普生物技術 ETF - SPDR

動態生物技術與基因組 ETF - Invesco

紐交所高增長板生物技術指數 ETF - First Trust

10X Health System 和 Verséa Discovery 推出 10X MitoScreen™，這是一項新一代的線粒體評估測試